Description of Changes in NIRS as a Function of Ductus Arteriosus Status in Very Premature Babies Born Before 32 WG at the DIJON University Hospital
- Conditions
- Extremely Premature Newborn (Born Before 32 Weeks' Gestation)
- Interventions
- Other: Collection of brain and kidney NIRS measurementsOther: echocardiography
- Registration Number
- NCT06153771
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Brief Summary
Monitoring patent ductus arteriosus is currently performed using echocardiography, an operator-dependent examination which requires holding the child on their back and which is potentially time-consuming. This test is usually carried out on days 2, 4 and 7 after birth.
NIRS (near-infrared spectroscopy) is a non-invasive method of monitoring tissue oxygen saturation using infrared light.
The aim of the study was to investigate an association between cerebral and renal NIRS data and ductus arteriosus status obtained by echocardiography.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 140
- Parent who has agreed to participate in the study
- Very premature newborn (born before 32 weeks' gestation)
- Hospitalised in the Neonatal Intensive Care Unit at Dijon University Hospital
- Before 48 hours of life
- Newborn with congenital heart disease
- Newborn with a congenital renal anomaly
- Newborn with polymalformative syndrome
- Newborn with a skin anomaly
- Newborn with severe circulatory failure unrelated to the ductus arteriosus
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Extremely premature newborn Collection of brain and kidney NIRS measurements (born before 32 weeks' gestation) Extremely premature newborn echocardiography (born before 32 weeks' gestation)
- Primary Outcome Measures
Name Time Method The ultrasound status of the ductus arteriosus On day 2, day 4 and day 7 of life (haemodynamically significant open, non-haemodynamically significant open, closed)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chu Dijon Bourgogne
🇫🇷Dijon, France